Determination of N-nitrosodimethylamine in Ranitidine Dosage Forms by ESI-LC-MS/MS; Applications for Routine Laboratory Testing
Open Access
- 1 January 2021
- journal article
- research article
- Vol. 20 (4) , 255-264
Abstract
A practical high-performance liquid chromatography-mass spectrometry method was developed for the analysis of N-nitrosodimethylamine (NDMA) characterized as an impurity, in combination with reports of the carcinogen found in ranitidine samples. After simple extraction of ranitidine samples, all compounds were analyzed with a high-performance liquid chromatography-mass spectrometry. Sensitivity was enhanced by employing the ten-way valve switching technology, which was examined to allow NDMA to enter the mass spectrometry and cut out the ranitidine samples extremely. A good linear relationship was observed within 3-100 ng.mL(-1) (r = 0.9992). The validated approach was effectively used to evaluate the NDMA contents in ranitidine samples in circulation, which revealed a difference among 21 batches. Quantitative determination of NDMA was within the scope of 3.38-57.05 ng.mL(-1). Moreover, the contamination levels of NDMA in seven batches of products from six manufacturers were listed to exceed the acceptable daily intake The sensitive method was verified to be appropriate to determine NDMA, even with low contents of NDMA in ranitidine products; the analysis of the selected samples reveals that some samples exceeded the national limit requirements. Therefore, it is worthwhile to conduct comprehensive quality control of the other drugs containing NDMA.Keywords
This publication has 18 references indexed in Scilit:
- Ranitidine in short supply: why now, and where next?Archives of Disease in Childhood, 2020
- Understanding and Preventing ( N -Nitrosodimethylamine) NDMA Contamination of MedicationsAnnals of Pharmacotherapy, 2019
- Rapid and efficient high-performance liquid chromatography analysis of N-nitrosodimethylamine impurity in valsartan drug substance and its productsScientific Reports, 2019
- The contamination of valsartan and other sartans, part 1: New findingsJournal of Pharmaceutical and Biomedical Analysis, 2019
- The contamination of valsartan and other sartans, Part 2: Untargeted screening reveals contamination with amides additionally to known nitrosamine impuritiesJournal of Pharmaceutical and Biomedical Analysis, 2019
- Analysis of an Impurity, N-Nitrosodimethylamine, in Valsartan Drug Substances and Associated Products Using GC-MSBiological and Pharmaceutical Bulletin, 2019
- NDMA impurity in valsartan and other pharmaceutical products: Analytical methods for the determination of N-nitrosaminesJournal of Pharmaceutical and Biomedical Analysis, 2019
- Characterization of N-nitrosodimethylamine formation from the ozonation of ranitidineJournal of Environmental Sciences, 2017
- Retracted: Oral intake of ranitidine increases urinary excretion of N-nitrosodimethylamineCarcinogenesis, 2016
- NDMA Formation by Chloramination of Ranitidine: Kinetics and MechanismEnvironmental Science & Technology, 2012